Antimicrobial peptides are small molecules with activity against bacteria, yeasts, fungi,
viruses, bacteria, and even tumor cells that make these molecules attractive as therapeutic …

The development of a vaccine for Fasciola spp. in livestock is a challenge and would be
advanced by harnessing our knowledge of acquired immune mechanisms expressed by …

Background Schistosomiasis continues to be a significant public health problem. This
disease affects 200 million people worldwide and almost 800 million people are at risk of …

Infection with the human liver fluke, Opisthorchis viverrini, is a serious public health problem
in Thailand, Laos and nearby locations in Southeast Asia. Both experimental and …

Background The membrane-associated and membrane-spanning constituents of the
Schistosoma mansoni tegument surface, the parasite's principal interface with the host …

Currently, three recombinant antigens based vaccines are under clinical trials against
Schistosomiasis, but there is no vaccine available for prophylaxis or therapeutic. This study …

A digenetic platyhelminth Schistosoma is the causative agent of schistosomiasis, one of the
neglected tropical diseases that affect humans and animals in numerous countries in the …

The successful development of vaccines depends on the knowledge of the immunological
mechanisms associated with the elimination of the pathogen. In the case of schistosomes, its …

The development of a vaccine against schistosomiasis and also the availability of a more
sensitive diagnosis test are important tools to help chemotherapy in controlling disease …

In the last few years, annexins have been discovered in several nematodes and other
parasites, and distinct differences between the parasite annexins and those of the hosts …